Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
NuMedii
NuMedii is a next-generation biopharma company that leverages Big Data and Artificial Intelligence (AI) to accelerate the discovery of precision therapies. Their proprietary AIDD (Artificial…
NuMedii
NuMedii is a next-generation biopharma company that leverages Big Data and Artificial Intelligence (AI) to accelerate the discovery of precision therapies. Their proprietary AIDD (Artificial…
TL;DR
What they do: AI/Big‑Data driven drug discovery and drug repurposing
Founded: 2008
Headquarters: Menlo Park / San Mateo area, California
Industry: Biotechnology
Known funding: $5.5M disclosed (Series A entries in 2013 and 2015)
Company Overview
Problem Domain
Accelerating drug discovery and repurposing by analyzing large-scale human biological, pharmacological, and clinical datasets.
Founded
2008
Industry
Biotechnology
Funding Track Record
$3.5M
$2.0M
Additional investors on the round reported: Seraph Group, StartX (Stanford-StartX Fund), TSVC
Investor Signal
“Venture-backed (investors include Lightspeed Venture Partners, Claremont Creek Ventures, Seraph Group, StartX, TSVC, Life Science Angels)”